Director/PDMR Shareholding
Source: RNS
ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or the "Group")
Director/PDMR Shareholding
Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, announces that on 29 November 2021, the Company was notified that on that same day Nicholas Willott, Finance Director and PDMR of the Company, purchased 7,690 ordinary shares of 0.005 pence each ("Ordinary Shares") at a price of 650p per Ordinary Share.
Following the purchase, Nicholas Willott's beneficial holding is 277,145 Ordinary Shares representing 0.60 per cent of the issued share capital of the Company.
For further Information please contact:
|
Elixirr International plc Stephen Newton, CEO Graham Busby, CFO
|
|
|
|
Public and Investor Relations contacts: Caroline Pitt
finnCap Ltd (Nominated Adviser & Sole Broker) Christopher Raggett, Simon Hicks, Kate Bannatyne (Corporate Finance) Alice Lane, Sunila De Silva (ECM)
|
investor-relations@elixirr.com
+44 (0)20 7220 0500 |
|
|
|
|
|
About Elixirr International plc
Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.
Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Nicholas Willott |
||||
|
2. |
Reason for the Notification |
|||||
|
a) |
Position/status |
Finance Director / PDMR |
||||
|
b) |
Initial notification/Amendment |
Initial Notification |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Elixirr International plc |
||||
|
b) |
LEI |
213800MKY7OHMVAKW681 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the Financial instrument, type of instrument |
Ordinary shares of 0.005p each ("Ordinary Shares") |
||||
|
Identification code |
GB00BLPHTX84 |
|||||
|
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information:
|
7,690 shares at 650p
|
||||
|
e) |
Date of the transaction |
29 November 2021 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, AIM market (XLON) |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
